The content on this site is intended for healthcare professionals only
Prostate & urology
Lung & pleura
Colorectal & gastro
Melanoma & skin
Head & neck
Ovary & gynaecology
Brain & nervous system
cancer and the City Cancer Challenge have formed an educational collaboration. Learners who are part of the City Cancer Challenge's project can access additional education provided by them.
Please login or register. Then you can use this button to confirm you are part of this project.
Register for free
Already have an account?
Tumour ‘signatures’ could provide key to more accurate treatment for deadliest cancers
Molecule that combines three distinct technologies against most aggressive type of brain cancer is t...
EHA 2022: Dysregulation of RNA binding proteins drive hematopoietic stem cell exhaustion and bone ma...
Novel DNA aptamer for CYP24A1 inhibition ID’d, possible target for anticancer therapy
Bridge therapy may benefit some children with high-risk neuroblastoma
ASCO 2022: Dabrafenib plus trametinib significantly increases overall response rate in paediatric lo...
Meta-analysis shows targeted radiation therapy may be as effective as standard care for small cell l...
ASCO 2022: Immunotherapy drug combination is safe with promising results in glioblastoma
A nanoparticle and inhibitor trigger the immune system, outsmarting brain cancer
Epilepsy drug stops nervous system tumour growth in mice